未登录
分享
收藏
分享
收藏RESULTS FROM AN ONGOING OPEN-LABEL, MULTICENTER, PHASE 1 TRIAL OF CCX559, AN ORALLY ADMINISTERED SMALL MOLECULE PD-L1 INHIBITOR, IN PATIENTS WITH ADVANCED SOLID TUMORS
Tapia-Rico, Gonzalo; Lundy, Joanne; Richardson, Gary; Zhao, Niky; Ebsworth, Karen; Yue, Huibin; Miao, Shichiang; deGoma, Emil; Jain, Rita; Schall, Thomas; Sullivan, Kathleen; Zhang, Penglie; de Souza, Paul; deGoma, Emil
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏